Quantel Medical Receives FDA Clearance for Ophthalmic Laser System

Quantel Medical has announced it has received FDA clearance for an ophthalmic laser system, according to a news release (pdf).

 

The SupraScan 577 laser is designed to treat retinal diseases. The company says the system combines 577nm yellow wavelength, pattern-scanning and MicroPulse tissue-sparing laser emission modes.

 

"We are proud to have passed this regulatory milestone," said Jean-Marc Gendre, CEO of Quantel Medical, in the release. "Quantel was the first company in the world to bring to market a solid-state green retina laser in 1993, followed by a solid-state yellow retina laser in 2008. Today's announcement of 510(k) clearance for the SupraScan 577, the most advanced solidstate yellow scanning retina laser allows Quantel USA to offer a market-changing solution to retina specialists in the United States."

 

Quantel Medical is headquartered in France.

 

Related Articles on FDA Clearances:

Teleflex Receives FDA Clearance Vascular Access Catheter

Avinger Receives FDA Clearance for Optical Coherence Tomography Catheter

LDR Receives FDA Conditional Approval for Cervical Disc

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast